Global Health Ltd (Medanta) (NSE: MEDANTA) and Narayana Hrudayalaya Limited (NSE: NH) are both listed in the Hospitals and Healthcare Centers industry. Global Health has a market capitalisation of ₹34,910 Cr and Narayana Hrudayalaya ₹37,253 Cr, as of 9 Nov 2026. Their P/E ratios are 62.8 and 46 respectively. Return on equity is 15.03% for Global Health and 19.85% for Narayana Hrudayalaya. Over one year, Global Health's share price is up 12.1% and Narayana Hrudayalaya's is up 5.9%.
| Metric | Global Health | Narayana Hrudayalaya |
|---|---|---|
| NSE Symbol | MEDANTA | NH |
| BSE Code | 543654 | 539551 |
| Share Price | ₹1,429.30 | ₹1,889.70 |
| Market Cap | ₹34,910 Cr | ₹37,253 Cr |
| P/E Ratio | 62.8 | 46 |
| Return on Equity | 15.03% | 19.85% |
| Return on Assets | 8.22% | 7.40% |
| Dividend Yield | 0.04% | 0.25% |
| Beta (1Y) | 0.31 | 0.15 |
| 1-Year Price Change | +12.1% | +5.9% |
| 3-Month Price Change | -3.2% | +3.0% |
| 52-Week Range | ₹956.00 – ₹1,544.00 | ₹1,589.00 – ₹2,093.30 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹1,469 Cr | ₹2,844 Cr |
| Quarterly Net Profit | ₹219 Cr | ₹301 Cr |
| Net Margin | 14.9% | 10.6% |
| EPS (Basic, Quarter) | ₹8.21 | ₹14.82 |
| Results Basis | consolidated | consolidated |
| Headquarters | Gurugram, Haryana | Bengaluru, Karnataka |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology an…
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medici…
Narayana Hrudayalaya has a market capitalisation of ₹37,253 Cr, against ₹34,910 Cr for Global Health as of 9 Nov 2026, so the two are about the same size by market cap.
Global Health has a P/E of 62.8 and Narayana Hrudayalaya a P/E of 46 as of 9 Nov 2026.
Global Health has a return on equity of 15.03% and Narayana Hrudayalaya 19.85%.
Global Health's share price is up 12.1% over one year and Narayana Hrudayalaya's is up 5.9%.
Global Health reported revenue of ₹1,469 Cr and net profit of ₹219 Cr for Q2 FY27. Narayana Hrudayalaya reported revenue of ₹2,844 Cr and net profit of ₹301 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.